Сerebrovascular Disorders in Patients with End-Stage Chronic Kidney Disease
Keywords:
Stroke, Cerebral autoregulation, Cerebral blood flow, Chronic kidney disease, ArteriosclerosisAbstract
Given the increasing worldwide prevalence of chronic kidney disease (CKD), it is critical to decrease the associated risk of debilitating vascular complications, including stroke, congestive heart failure, myocardial infarction, and peripheral vascular disease. Treatment options for reducing the risk of all subtypes of stroke in patients with CKD remain limited. For patients with end-stage kidney disease (ESKD), novel applications of noninvasive imaging may help personalize the type of dialysis and dialysis prescription for patients at high-risk.
References
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. (2013) 382:260–72. doi: 10.1016/S0140-6736(13)60687-X
Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. (2002) 13:1918–27. doi: 10.1097/01.ASN.0000019641.41496.1E
Fabjan TH, Hojs R. Stroke and renal dysfunction. Eur J Int Med. (2014) 25:18–24. doi: 10.1016/j.ejim.2013.08.710
Kockelkoren R, Vos A, van Hecke W, Vink A, Bleys RLAW, Verdoorn D, et al. Computed tomographic distinction of intimal and medial calcification in the intracranial internal carotid artery. PLoS ONE. (2017) 12:e0168360. doi: 10.1371/journal.pone.0168360
Toyoda K, Ninomiya T. Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol. (2014) 13:823–33. doi: 10.1016/S1474-4422(14)70026-2
Shima H, Ishimura E, Naganuma T, Ichii M, Yamasaki T, Mori K, et al. Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities. Kidney Blood Press Res. (2011) 34:430–8. doi: 10.1159/000328722
Chillon JM, Massy ZA, Stengel B. Neurological complications in chronic kidney disease patients. Nephrol Dial Transplant. (2016) 31:1606–14. doi: 10.1093/ndt/gfv315Lee M, Saver JL, Chang K-H, Liao H-W, Chang S-C, Ovbiagele B. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. (2010) 341:c4249. doi: 10.1136/bmj.c4249
Masson P, Webster AC, Hong M, Turner R, Lindley RI, Craig JC. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. (2015) 30:1162–69. doi: 10.1093/ndt/gfv009
van Norden AG, et al. Frontal and temporal microbleeds are related to cognitive function: the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study. Stroke. 2011;42(12):3382–3386. doi: 10.1161/STROKEAHA.111.629634.
Poels MM, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012;78(5):326–333. doi: 10.1212/WNL.0b013e3182452928.
Wardlaw JM, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. doi: 10.1016/S1474-4422(13)70124-8
Shima H, et al. Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant. 2010;25(5):1554–1559. doi: 10.1093/ndt/gfp694.
Naganuma T, et al. Cerebral microbleeds predict intracerebral hemorrhage in hemodialysis patients. Stroke. 2015;46(8):2107–2112. doi: 10.1161/STROKEAHA.115.009324.
Xiao L, et al. Correlation between cerebral microbleeds and S100B/RAGE in acute lacunar stroke patients. J Neurol Sci. 2014;340(1–2):208–212. doi: 10.1016/j.jns.2014.03.006. 17.Charidimou A, Werring DJ. A raging fire in acute lacunar stroke: inflammation, blood-brain barrier dysfunction and the origin of cerebral microbleeds. J Neurol Sci. 2014;340(1–2):1–2. doi: 10.1016/j.jns.2014.03.004.
Isoyama N, et al. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. Nephrol Dial Transplant. 2015;30(1):84–91. doi: 10.1093/ndt/gfu259.
19.Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial. 2006;19(4):317–322. doi: 10.1111/j.1525-139X.2006.00179.x.
Cases A, et al. Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Int. 1992;42(3):668–672. doi: 10.1038/ki.1992.333.
Diaz-Ricart M, et al. Erythropoietin improves signaling through tyrosine phosphorylation in platelets from uremic patients. Thromb Haemost. 1999;82(4):1312–1317.
Weiner DE, Scott TM, Giang LM, Agganis BT, Sorensen EP, Tighiouart H, et al. Cardiovascular disease and cognitive function in maintenance Hemodialysis patients. Am J Kidney Dis. (2011) 58:773–81. doi: 10.1053/j.ajkd.2011.03.034
Toyoda G, Bokura H, Mitaki S, Onoda K, Oguro H, Nagai A, et al. Association of mild kidney dysfunction with silent brain lesions in neurologically normal subjects. Cerebrovasc Dis Extra. (2015) 5:22–7. doi: 10.1159/0003
Etgen T. Kidney disease as a determinant of cognitive decline and dementia. Alzheimer's Res Ther. (2015) 7:29. doi: 10.1186/s13195-015-0115-4
Ohara T, Kokubo Y, Toyoda K, Watanabe M, Koga M, Nakamura S, et al. Impact of chronic kidney disease on carotid atherosclerosis according to blood pressure category: the Suita study.
Dad T, Weiner DE. Stroke and chronic kidney disease: epidemiology, pathogenesis, and management across kidney disease stages. Semin Nephrol 2015 Jul;35(4):311–22.2.
Toyoda K, Ninomiya T. Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol 2014 Aug;13(8):823–33.3.
Arnold J, Sims D, Ferro CJ. Modulation of stroke risk in chronic kidney disease. Clin Kidney J 2016 Feb;9(1):29–38.4.
Murray AM, Seliger S, Lakshminarayan K, Herzog CA, Solid CA. Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol 2013 Jun;24(7):1166–73.
Yahalom G, Schwartz R, Schwammenthal Y, Merzeliak O, Toashi M, Orion D, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. 2009 Apr;40(4):1296–303.
Arnold R, Issar T, Krishnan AV, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis 2016 Nov 3;5:2048004016677687.
Krishnan AV, Kiernan MC. Neurological complications of chronic kidney disease. Nat Rev Neurol 2009 Oct;5(10):542–51.
Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 2003 Aug;64(2):610–5.
Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010 Sep 30;341:c4249.
Ovbiagele B, Bath PM, Cotton D, Sha N, Diener HC; PRoFESS Investigators. Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation. 2013 Nov;44(11):3223–5.
Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adamu S, Plange-Rhule J, Ansong D, et al. Estimated glomerular filtration rate predicts incident stroke among Ghanaians with diabetes and hypertension. J Neurol Sci 2019 Jan;396:140–7.
Gutiérrez OM, Judd SE, Muntner P, Rizk DV, McClellan WM, Safford MM, et al. Racial differences in albuminuria, kidney function, and risk of stroke.2012 Oct;79(16):1686–92.
Muntner P, Judd SE, McClellan W, Meschia JF, Warnock DG, Howard VJ. Incidence of stroke symptoms among adults with chronic kidney disease: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Nephrol Dial Transplant 2012 Jan;27(1):166–73.
Gutiérrez OM, Irvin MR, Chaudhary NS, Cushman M, Zakai NA, David VA, et al. APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults. 2018 Jun;11(6):e002098.
Akinyemi R, Tiwari HK, Arnett DK, Ovbiagele B, Irvin MR, Wahab K, et al.; SIREN Investigators. APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke 2018 Jan;137(1):133–41.
